| Date | Time | Source | Headline | Symbol | Company |
| 04/08/2019 | 8:58AM | Alliance News |  MaxCyte Launches ExPERT Cellular Engineering Technology Platform | LSE:MXCT | Maxcyte Inc |
| 04/08/2019 | 2:00AM | UK Regulatory | MaxCyte, Inc. Launch of ExPERTT Instrument Family | LSE:MXCT | Maxcyte Inc |
| 03/26/2019 | 3:01AM | UK Regulatory | MaxCyte, Inc. Notice of Full Year Results | LSE:MXCT | Maxcyte Inc |
| 03/19/2019 | 1:05PM | UK Regulatory | MaxCyte, Inc. Director Dealings | LSE:MXCT | Maxcyte Inc |
| 03/05/2019 | 2:00AM | UK Regulatory | MaxCyte, Inc. Grant of Options | LSE:MXCT | Maxcyte Inc |
| 03/01/2019 | 5:05AM | Alliance News | MaxCyte Inks Multi-Drug Clinical And Commercial Agreement With Kite | LSE:MXCT | Maxcyte Inc |
| 03/01/2019 | 4:23AM | Dow Jones News | MaxCyte Partners With Gilead to Develop CAR-T Therapy | LSE:MXCT | Maxcyte Inc |
| 03/01/2019 | 2:01AM | UK Regulatory | MaxCyte, Inc. Clinical & Commercial Agreement with Kite | LSE:MXCT | Maxcyte Inc |
| 02/26/2019 | 12:32PM | UK Regulatory | MaxCyte, Inc. Result of Special Meeting and Issue of Equity | LSE:MXCT | Maxcyte Inc |
| 02/05/2019 | 12:45PM | Alliance News | UPDATE: MaxCyte Placing Fully Subscribed; Raises Over GBP10.0 Million (ALLISS) | LSE:MXCT | Maxcyte Inc |
| 02/05/2019 | 11:32AM | UK Regulatory | MaxCyte, Inc. Results of Placing | LSE:MXCT | Maxcyte Inc |
| 02/05/2019 | 5:22AM | Alliance News | MaxCyte To Raise At Least GBP10 Million For Future Growth Plans (ALLISS) | LSE:MXCT | Maxcyte Inc |
| 02/05/2019 | 2:00AM | UK Regulatory | MaxCyte, Inc. Proposed Placing to raise a minimum of £10 million | LSE:MXCT | Maxcyte Inc |
| 01/15/2019 | 6:18AM | Alliance News | MaxCyte Guides For Revenue Growth And Earnings Above Expectations | LSE:MXCT | Maxcyte Inc |
| 01/15/2019 | 2:00AM | UK Regulatory | MaxCyte, Inc. Trading Update | LSE:MXCT | Maxcyte Inc |
| 12/19/2018 | 2:00AM | UK Regulatory | MaxCyte, Inc. Change of Auditor | LSE:MXCT | Maxcyte Inc |
| 12/17/2018 | 1:06PM | UK Regulatory | MaxCyte, Inc. Director Dealings | LSE:MXCT | Maxcyte Inc |
| 11/21/2018 | 2:01AM | UK Regulatory | MaxCyte, Inc. Consolidation of Trading Lines | LSE:MXCT | Maxcyte Inc |
| 11/20/2018 | 2:01AM | UK Regulatory | MaxCyte, Inc. Block Admission Six Monthly Return/TVR | LSE:MXCT | Maxcyte Inc |
| 11/16/2018 | 2:00AM | UK Regulatory | MaxCyte, Inc. Webinar: non-viral cell engineering | LSE:MXCT | Maxcyte Inc |
| 11/14/2018 | 6:52AM | Alliance News | MaxCyte Signs Technology Licence Agreement With Precision BioSciences | LSE:MXCT | Maxcyte Inc |
| 11/14/2018 | 2:00AM | UK Regulatory | MaxCyte, Inc. Clinical and Commercial License Agreement | LSE:MXCT | Maxcyte Inc |
| 11/12/2018 | 6:07AM | Alliance News | MaxCyte Signs Research Agreement For Non-Viral Cell Engineering | LSE:MXCT | Maxcyte Inc |
| 11/12/2018 | 2:00AM | UK Regulatory | MaxCyte, Inc. MaxCyte Announces Research Agreement with Kite | LSE:MXCT | Maxcyte Inc |
| 11/09/2018 | 7:03AM | Alliance News | MaxCyte Signs Gene Editing Licence Agreement With CRISPR Therapeutics | LSE:MXCT | Maxcyte Inc |
| 11/09/2018 | 2:00AM | UK Regulatory | MaxCyte, Inc. Expansion of CRISPR Commercial License Agreement | LSE:MXCT | Maxcyte Inc |
| 10/31/2018 | 12:25PM | UK Regulatory | MaxCyte, Inc. Result of AGM | LSE:MXCT | Maxcyte Inc |
| 10/10/2018 | 6:47AM | Alliance News | MaxCyte Begins Patient Trial Of Proposed Cancer Treatment MCY-M11 | LSE:MXCT | Maxcyte Inc |
| 10/10/2018 | 2:00AM | UK Regulatory | MaxCyte, Inc. Dosing Begins in First Clinical Trial of MCY-M11 | LSE:MXCT | Maxcyte Inc |
| 10/08/2018 | 2:00AM | UK Regulatory | MaxCyte, Inc. Notice of AGM | LSE:MXCT | Maxcyte Inc |